Healthcare -
Biotechnology - NASDAQ - US
$ 0.4745
-0.939 %
$ 18.2 M
Market Cap
-0.28
P/E
BOLT - COST OF REVENUE
Cost of Revenue BOLT - Bolt Biotherapeutics, Inc.
1.88 M
LAST VALUE
-28.37%
2 YEAR CAGR
44.22%
5 YEAR CAGR
0.00%
10 YEAR CAGR